TherapeuticsMD
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $547 | $234 | $313 | $502 |
Gross Profit | 547 | 234 | 180 | -135 |
EBITDA | -474 | -864 | -676 | -974 |
EBIT | -570 | -1,044 | -809 | -1,611 |
Net Income | -609 | -1,090 | -734 | -883 |
Net Change In Cash | 547 | 234 | 313 | 502 |
Free Cash Flow | 248 | 894 | 11 | -7,841 |
Cash | 5,047 | 5,232 | 4,338 | 4,327 |
Basic Shares | 11,532 | 11,532 | 11,532 | 11,532 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,302 | $69,963 | $86,951 | $64,872 |
Gross Profit | 1,302 | 68,566 | 68,113 | 48,897 |
EBITDA | -8,401 | 11,856 | -78,569 | -149,471 |
EBIT | -8,523 | 10,663 | -79,305 | -154,943 |
Net Income | -10,278 | 111,997 | -205,604 | -212,702 |
Net Change In Cash | 1,302 | 69,963 | 86,951 | 64,872 |
Cost of Revenue | -15,364 | -80,343 | ||
Free Cash Flow | -48,141 | -4,433 | -144,916 | -161,068 |
Cash | 4,327 | 38,067 | 65,122 | 80,485 |
Basic Shares | 10,441 | 9,028 | 7,960 | 5,512 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.05 |
2024-06-30 | -$0.09 |
2024-03-31 | -$0.07 |
2023-12-31 | -$0.08 |
